Abkyu and Jeevan Therapeutics Announce Strategic VHH Discovery Agreement

WATERTOWN, Mass., September 2, 2025 — Abkyu, Inc., a biotechnology company specializing in single-domain antibody (VHH) discovery, today announced a strategic discovery partnership with Jeevan Therapeutics, a biotechnology company founded by experienced industry leaders in biologics and small molecule development. The collaboration, valued at up to $200 million, will leverage Abkyu’s proprietary VHH discovery platform […]